| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Complex carbohydrate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Refined carbohydrate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate derivative |
Is a |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Gamma-ketovaleric acid (substance) |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Pectin |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Polysaccharide |
Is a |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Simple carbohydrate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Saccharides measurement |
Has measured component (attribute) |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Malabsorption due to intolerance to carbohydrate |
Causative agent (attribute) |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate identification |
Has measured component (attribute) |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Saccharides measurement |
Component |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate identification |
Component |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Metabolic acidosis due to grain overload (disorder) |
Causative agent (attribute) |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Product containing glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.225%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.18%/glucose 4% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.18%/glucose 10% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.45%/glucose 2.5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.45%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.9%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing carbohydrate (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 60g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 25% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| 60 minute plasma xylose level (procedure) |
Component |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate supplementation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Complex carbohydrate supplementation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Refined carbohydrate supplementation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Stilbestrol+lactic acid 500micrograms/5% pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Intravenous nutrition (carbohydrate) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing aspartame (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing diethylstilbestrol and lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5% in 0.2% Normal Saline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Cholestyramine+aspartame |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.18%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 1000mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 60% in water intravenous solution 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 150mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Infant dextrose 25% injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 500mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 60% in water intravenous solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 10mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL (5%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Salicylic acid+lactic acid 16.7%/16.7% paint |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.18%/glucose 4% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.18%/glucose 4% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.18%/glucose 4% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.9%/glucose 5% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.9%/glucose 5% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sodium chloride 0.9%/glucose 5% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing acesulfame potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 10% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 30% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 40% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Glucose 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 60% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 70% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Alcohol + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Theophylline + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactated Ringer's solution + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactated Ringer's solution and 2.5% dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactated Ringer's solution + 5% dextrose + 0.15% potassium hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Milrinone + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Morphine sulfate + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Bupivacaine + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Cefoxitin + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Colestyramine+aspartame 4g/sachet s/f oral powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Bupivacaine hydrochloride 7.5mg/dextrose 82.5mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sugar phosphate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Sugar alcohol |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 10mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 10mmol/dextrose 5%/saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 13.5mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 27mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 40mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium+dextrose infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium+dextrose/saline infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Potassium chloride 10%/saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate food |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Sugar acid (substance) |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Intravenous nutrition (carbohydrate) adverse reaction |
Causative agent (attribute) |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Oligosaccharide |
Is a |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate measurement |
Component |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Wheat dextrin |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]